![Andrew Carry Kruegel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Andrew Carry Kruegel is the founder of Gilgamesh Pharmaceuticals, Inc. and holds the title of Chief Scientific Officer since 2019.
Dr. Kruegel is the founder of Kures, Inc. and holds the title of President & Director.
Postes actifs de Andrew Carry Kruegel
| Sociétés | Poste | Début |
|---|---|---|
Kures, Inc.
 Kures, Inc. BiotechnologyHealth Technology Develops therapeutics for mood disorders | President | - |
Gilgamesh Pharmaceuticals, Inc.
 Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel neuropsychiatric medicines for treatment of depression, anxiety and schizophrenia | Fondateur | 01/01/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Kures, Inc.
Kures, Inc. BiotechnologyHealth Technology Develops therapeutics for mood disorders | Health Technology |
Gilgamesh Pharmaceuticals, Inc.
Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel neuropsychiatric medicines for treatment of depression, anxiety and schizophrenia | Health Technology |
